BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 35443910)

  • 1. Two cases of dupilumab-associated eosinophilic pneumonia in asthma with eosinophilic chronic rhinosinusitis: IL-5-driven pathology?
    Nishiyama Y; Koya T; Nagano K; Abe S; Kimura Y; Shima K; Toyama-Kosaka M; Hasegawa T; Sasaki T; Shinbori K; Ueki S; Takamura K; Kikuchi T
    Allergol Int; 2022 Oct; 71(4):548-551. PubMed ID: 35443910
    [No Abstract]   [Full Text] [Related]  

  • 2. Eosinophilic pulmonary complications of dupilumab in 2 patients with asthma and chronic rhinosinusitis with nasal polyps.
    Frohlich M; Olivenstein R; Cormier M
    J Allergy Clin Immunol Pract; 2022 Feb; 10(2):617-619. PubMed ID: 34929373
    [No Abstract]   [Full Text] [Related]  

  • 3. Dupilumab in pediatric severe chronic rhinosinusitis with nasal polyps and asthma.
    Bragança M; Pereira AM; Plácido JL; Amaral L
    Eur Ann Otorhinolaryngol Head Neck Dis; 2024 Jan; 141(1):55-56. PubMed ID: 37591762
    [No Abstract]   [Full Text] [Related]  

  • 4. [Impact of reslizumab on the course of chronic rhinosinusitis in patients with eosinophilic asthma].
    Boiko NV; Lodochkina OE; Kit MM; Kuleshova VG; Nedashkovskaya NG
    Vestn Otorinolaringol; 2021; 86(2):43-48. PubMed ID: 33929151
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cycling therapy with benralizumab and dupilumab for severe eosinophilic asthma with eosinophilic chronic rhinosinusitis and eosinophilic otitis media.
    Hamada S; Ogino E; Yasuba H
    Allergol Int; 2021 Jul; 70(3):389-391. PubMed ID: 33685801
    [No Abstract]   [Full Text] [Related]  

  • 6. [Blood eosinophilia in patients with severe bronchial asthma and chronic polypous rhinosinusitis treated with dupilumab: A review].
    Petukhova AY; Gromov AS; Solovyov RV; Filippova SG; Prokopieva ER
    Ter Arkh; 2024 Apr; 96(3):303-308. PubMed ID: 38713048
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of Dupilumab on Blood Eosinophil Counts in Patients With Asthma, Chronic Rhinosinusitis With Nasal Polyps, Atopic Dermatitis, or Eosinophilic Esophagitis.
    Wechsler ME; Klion AD; Paggiaro P; Nair P; Staumont-Salle D; Radwan A; Johnson RR; Kapoor U; Khokhar FA; Daizadeh N; Chen Z; Laws E; Ortiz B; Jacob-Nara JA; Mannent LP; Rowe PJ; Deniz Y
    J Allergy Clin Immunol Pract; 2022 Oct; 10(10):2695-2709. PubMed ID: 35636689
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of Dupilumab on Depression in Asthma with Eosinophilic Chronic Rhinosinusitis in the Japanese Population.
    Koya T; Sakai N; Sasaki T; Shinbori K; Nagai A; Kimura Y; Toyama M; Hayashi M; Saito A; Nishiyama Y; Hasegawa T; Muramatsu Y; Muramatsu K; Horii A; Kikuchi T
    Int Arch Allergy Immunol; 2022; 183(3):289-297. PubMed ID: 34657036
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy and Safety of Dupilumab Versus Omalizumab in Chronic Rhinosinusitis With Nasal Polyps and Asthma: EVEREST Trial Design.
    De Prado Gomez PharmD MSc L; Khan Mbbs Mph AH; Peters Md AT; Bachert Md PhD C; Wagenmann Md M; Heffler Md PhD E; Hopkins BMBCh C; Hellings Md PhD PW; Zhang PhD M; Xing PhD J; Rowe Md P; Jacob-Nara Md Mph DHSc JA
    Am J Rhinol Allergy; 2022 Nov; 36(6):788-795. PubMed ID: 35837739
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Global influence of dupilumab on Quality of Life in a severe asthma patient with T2 multimorbidities: a case report on atopic dermatitis, chronic rhinosinusitis with nasal polyposis, and eosinophilic esophagitis.
    Colque-Bayona M; Hernández-Cano N; Tomás-Pérez M; Caballero T; Quirce S; Domínguez-Ortega J
    J Asthma; 2024 Jul; 61(7):762-765. PubMed ID: 38152869
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Experience with dupilumab in the treatment of chronic rhinosinusitis with nasal polyps].
    Boiko NV; Stagnieva IV; Lodochkina OE; Kurbatova NV
    Vestn Otorinolaringol; 2023; 88(4):46-53. PubMed ID: 37767590
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adverse effects of dupilumab in chronic rhinosinusitis with nasal polyps. Case report and narrative review.
    Nitro L; Bulfamante AM; Rosso C; Saibene AM; Arnone F; Felisati G; Pipolo C
    Acta Otorhinolaryngol Ital; 2022 Jun; 42(3):199-204. PubMed ID: 35880360
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mepolizumab for chronic rhinosinusitis with nasal polyps.
    Brusselle GG; Gevaert P
    Lancet Respir Med; 2021 Oct; 9(10):1081-1082. PubMed ID: 33872589
    [No Abstract]   [Full Text] [Related]  

  • 14. [Chronic rhinosinusitis with nasal polyps : is there a place for monoclonal antibodies in 2020 ?].
    Clottu A; Reinhard A; Comte D
    Rev Med Suisse; 2021 Jan; 17(720-1):13-17. PubMed ID: 33443824
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Last station in the eosinophilic asthma with chronic rhinosinusitis and/or nasal polyposis march: Eosinophilic asthma with radiological findings associated with blood eosinophilia.
    Yılmaz I; Bahçecioğlu SN; Türk M; Tutar N; Oymak FS; Gülmez İ
    J Asthma; 2019 Feb; 56(2):111-117. PubMed ID: 29611776
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of Reslizumab on Asthma Outcomes in a Subgroup of Eosinophilic Asthma Patients with Self-Reported Chronic Rhinosinusitis with Nasal Polyps.
    Weinstein SF; Katial RK; Bardin P; Korn S; McDonald M; Garin M; Bateman ED; Hoyte FCL; Germinaro M
    J Allergy Clin Immunol Pract; 2019 Feb; 7(2):589-596.e3. PubMed ID: 30193936
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Real-life effects of dupilumab in patients with severe type 2 asthma, according to atopic trait and presence of chronic rhinosinusitis with nasal polyps.
    Pelaia C; Benfante A; Busceti MT; Caiaffa MF; Campisi R; Carpagnano GE; Crimi N; D'Amato M; Foschino Barbaro MP; Maglio A; Minenna E; Nolasco S; Paglino G; Papia F; Pelaia G; Portacci A; Ricciardi L; Scichilone N; Scioscia G; Triggiani M; Valenti G; Vatrella A; Crimi C
    Front Immunol; 2023; 14():1121237. PubMed ID: 37063895
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Persistent use of dupilumab in adults with asthma or chronic rhinosinusitis with nasal polyps.
    Corey KB; Moore R; Zuckerman AD; Littlejohn M; Cahill KN
    Ann Allergy Asthma Immunol; 2024 Mar; 132(3):390-391. PubMed ID: 37981023
    [No Abstract]   [Full Text] [Related]  

  • 19. Improvement in patient-reported "taste" and association with smell in dupilumab-treated patients with severe chronic rhinosinusitis with nasal polyps from the SINUS-24 and SINUS-52 trials.
    Peters AT; Soler ZM; Kern RC; Heffler E; Maspero JF; Crampette L; Fujieda S; Lane AP; Zhang H; Nash S; Khan AH; Siddiqui S; Jacob-Nara JA; Rowe P; Deniz Y
    Clin Exp Allergy; 2022 Sep; 52(9):1105-1109. PubMed ID: 35775319
    [No Abstract]   [Full Text] [Related]  

  • 20. Dupilumab improves upper and lower airway disease control in chronic rhinosinusitis with nasal polyps and asthma.
    Laidlaw TM; Bachert C; Amin N; Desrosiers M; Hellings PW; Mullol J; Maspero JF; Gevaert P; Zhang M; Mao X; Khan AH; Kamat S; Patel N; Graham NMH; Ruddy M; Staudinger H; Mannent LP
    Ann Allergy Asthma Immunol; 2021 May; 126(5):584-592.e1. PubMed ID: 33465455
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.